Myeloablative allogeneic versus autologous stem cell transplantation in adult patients with acute lymphoblastic leukemia in first remission: a prospective sibling donor versus no-donor comparison.

Translated title of the contribution: Myeloablative allogeneic versus autologous stem cell transplantation in adult patients with acute lymphoblastic leukemia in first remission: a prospective sibling donor versus no-donor comparison.

J.J. Cornelissen, B. van der Holt, G.E. Verhoef, M.B. van 't Veer, M.H. Oers, H.C. Schouten, G. Ossenkoppele, P. Sonneveld, J. Maertens, M. van Marwijk Kooy, M.R. Schaafsma, P.W. Wijermans, D.H. Biesma, S. Wittebol, P.J. Voogt, J.W. Baars, P. Zachée, L.F. Verdonck, B. Löwenberg, A.W. DekkerDutch-Belgian HOVON Cooperative Group on behalf of the

Research output: Contribution to journalArticleAcademicpeer-review

Translated title of the contributionMyeloablative allogeneic versus autologous stem cell transplantation in adult patients with acute lymphoblastic leukemia in first remission: a prospective sibling donor versus no-donor comparison.
Original languageUndefined/Unknown
Pages (from-to)1375-1382
Number of pages8
JournalBlood
Volume113
Issue number6
Publication statusPublished - 2009

Cite this